Observational analysis shows broad-spectrum inhibition of plant pathogenic fungi using bioactive metabolites, suggesting potential for disease management.
The most common reason for a decrease in the quantity and quality of produced crops is microbial diseases. The aims of this study were to evaluate the antagonistic activity of Streptomyces sp. CACIS-1.16CA against plant pathogenic fungi and to assess its bioactive metabolites to inhibit fungal conidial germination. Antagonistic evaluations of fungal phytopathogens were performed using dual and multiple confrontation assays. Additionally, the inhibitory effect of the bioactive extract (BE) containing secondary metabolites produced by the CACIS-1.16CA strain on the germination of conidia from some fungi was tested. The results indicate that Streptomyces sp. CACIS-16CA inhibited the growth of all tested pathogens (16 strains) with percentages of inhibition (PIs) ranging from 43.3% to 72%, while S. lydicus inhibited 13 of the 16 fungi, with PI values from 35.6% to 68.5%. Moreover, CACIS-1.16CA exerted superior PI values (significant differences at p < 0.05) than S. lydicus against the damping-off fungi consortia with Phytophthora capsici, Fusarium oxysporum, and Rhizoctonia solani. Otherwise, an inhibitory effect was observed on the germination of conidial cells due to the interaction with the BE in Alternaria sp., Botrytis cinerea, and Colletotrichum spp. In conclusion, Streptomyces sp. CACIS-1.16CA may serve as an effective and natural alternative for managing several fungal plant diseases.
No takes yet. Share an insight, caveat, or question.
Vargas-Gómez et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: